Call for Papers

Call For Papers

for

Mind Altering Science 2012
1-3 June 2012
University of Amsterdam, the Netherlands
Deadline: 19 February 2012

About the conference

With researchers and therapists from a wide variety of academic disciplines, this event will be dedicated to the exploration of a broad range of subjects relating to scientific research into psychedelic substances and the psychedelic experience. From addiction treatment to psychotherapy with the aid of psychedelics, from the neurobiology of ayahuasca to the social, ritual and legal implications of its use, and from human psychopharmacology research and the exploration of exceptional mindstates to new views on the legalisation of psychedelic substances. MAS was first organized in 2010, MAS2012 will be the second installment. We welcome papers within the broad and interdisciplinary field of psychedelic science. Researchers who are still in the process of writing are also strongly encouraged to submit. Poster presentations are also welcome to apply.

About the organizers

The OPEN Foundation: Research into the Psychedelic Experience Netherlands

The OPEN Foundation is an interdisciplinary initiative aimed at achieving the following goals. * To make psychedelics an accessible subject for both scientists and students who want to do research. * The acknowledgement of psychedelics as a legitimate academic subject at all Dutch universities. * To increase awareness of the (psycho-) therapeutic applications of psychedelics. * To stimulate media and politics to adopt an objective and evidence-based attitude towards psychedelics.

Submit your paper using the form below.

GUIDELINES FOR PAPER SUBMISSION :

Please indicate the type of presentation (presentation, poster, workshop) you prefer.

Abstracts should only be submitted with this form.

The deadline for abstract submission is February 19th, 2012.

Each author is allowed to submit a maximum of one abstract for each format (presentation, poster and workshop). Totalling a maximum of three submissions in total.

All abstracts must be submitted and presented in English.

Abbreviations should be defined the first time they appear in your text. Example: 5-Hydroxytryptamine (5-HT). Please, do not define or use abbreviations in the title.

The minimum length of the abstract is 500 characters. The abstract may not be longer than 200 words.

If your submitted abstract is accepted you will be contacted via e-mail by the end of april 2012 at the latest, and informed about further procedures.

Please include a (link to the) full text if it is available.